1. Ajani JA, Ota DM, Jessup JM, Ames FC, McBride C, Boddie A, Levine B, Jackson DE, Roh M, Hohn D (1991) Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501?1506
2. Wilke H, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Geerlings H (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17:61?70
3. Bertino JR, Sawicki WL, Lindquist CA (1977). Schedule-dependent antitumor effect of methotrexate and 5-fluorouracil. Cancer Res 37:327?328
4. Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Lightdale C, Vinciguerra V, Brennan M (1992) FAMTX versus etoposide, doxorubicin, and cisplatin: A random assignment trial in gastric cancer. J Clin Oncol 10:541?548
5. Japanese Research Society for Gastric Cancer (1993) The General Rules for Gastric Cancer Study, 12th edn. Kinbarashuppan, Tokyo, pp 1?57